Immunohistochemistry of breast tumor tissue arrays revealed that Bit1 is expressed in normal breast epithelial and Ductal Carcinoma In Situ (DCIS) tissues while decrease or loss of Bit1 expression was correlated with advanced invasive carcinoma tissues. This evidence concerns the gene PTRH2 and ductal breast carcinoma in situ.